Rebeccamycin analog
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Rebeccamycin analog, covering 2013-01-10 to 2014-01-01. Get the full timeline:
Most recent: Clinical Trial Update: Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy [Phase 2]